Search clinical trials for: MK-8998

Total 1719 results

Jazz Pharmaceuticals

Recruiting

A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease

Parkinson Disease | Tremor

United States, Spain, Germany, Poland
Merck Sharp & Dohme LLC

Completed

Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011) (POMOSCH)

Hepatitis C, Chronic
Xention Ltd

Completed

Bioequivalence Study of Capsule and Tablet Formulations of TA-8995

Dyslipidaemia

United Kingdom
Xention Ltd

Completed

ADME Study in Healthy Male Subjects With TA-8995

Dyslipidemia

United Kingdom
Jazz Pharmaceuticals

Completed

CX-8998 for Absence Seizures (T-WAVE)

Epilepsy

United States
Jazz Pharmaceuticals

Completed

A Phase 2 RCT Study of CX-8998 for Essential Tremor

Essential Tremor

United States
Jazz Pharmaceuticals

Withdrawn

A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease

Parkinson's Disease | Tremor
NewAmsterdam Pharma

Completed

Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

Early Alzheimer's Disease

Netherlands
Mitsubishi Tanabe Pharma Corporation

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects

Dyslipidemia

Germany
Xention Ltd

Completed

A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

Elevated Lp(a)

Denmark
Mitsubishi Tanabe Pharma Corporation

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects

Dyslipidemia

United Kingdom
BTL Industries Ltd.

Completed

Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen

Improvement of Abdomen Appearance

Bulgaria
BTL Industries Ltd.

Completed

Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms

Fat Burn

Bulgaria
BTL Industries Ltd.

Active, not recruiting

Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen

Fat Burn

United States
BTL Industries Ltd.

Completed

Histological Evaluation of BTL-899 Device´s Effect on Fat Tissue

Fat Burn

United States
BTL Industries Ltd.

Completed

rPMS and Radiofrequency for Abdominal Toning and Reduction of Subcutaneous Fat

Fat Burn

United States
BTL Industries Ltd.

Completed

Non-invasive Lipolysis on Human Thighs and Saddlebags

Adipose Tissue Reduction

Bulgaria
Curis, Inc.

Completed

Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies

Solid Tumor

United States, Australia
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms

Fat Disorder

United States
BTL Industries Ltd.

Completed

Fat Reduction and Muscle Toning of Thighs

Fat Burn

United States
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Inner Thighs

Fat Disorder

United States
BTL Industries Ltd.

Completed

Clinical Evaluation of the BTL-899 Device for Non-invasive Lipolysis on Human Fat Tissue

Improvement of Abdomen Appearance

Bulgaria
Biota Scientific Management Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

CS-8958 Single Inhaled Dose in Elderly

Influenza

United Kingdom
Biota Scientific Management Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958

Influenza

United Kingdom
BTL Industries Ltd.

Completed

High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks

Muscle Tone

United States
BTL Industries Ltd.

Unknown

Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen When Compared to a Sham Treatment

Improvement of Abdomen Appearance

Bulgaria
Merck Sharp & Dohme LLC

Terminated

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Neoplasms Malignant
Merck Sharp & Dohme LLC

Completed

A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)

Type 2 Diabetes Mellitus
BTL Industries Ltd.

Completed

Combination Treatment With BTL-899 and HPM-6000UF Devices II

Muscle Weakness

United States
Merck Sharp & Dohme LLC

Completed

A Single Rising Dose Study of MK-8150 (MK-8150-001)

Hypertension | Isolated Systolic Hypertension (ISH)
BTL Industries Ltd.

Active, not recruiting

Combination Treatment With BTL-899 and HPM-6000UF Devices

Pelvic Floor Disorders

United States
Merck Sharp & Dohme LLC

Completed

A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)

Schizophrenia
Merck Sharp & Dohme LLC

Completed

A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)

Schizophrenia

United States
Radboud University Medical Center

Completed

Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain (MCSNL)

Facial Pain | Pain, Intractable | Central Pain Syndrome
NeurogesX

Completed

Study of NGX-1998 for the Treatment of Postherpetic Neuralgia

Pain | Postherpetic Neuralgia

United States
Merck Sharp & Dohme LLC

Completed

A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)

Hepatitis C Virus Infection
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG) (MK-1064-003)

Polysomnography
Merck Sharp & Dohme LLC

Completed

Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)

Solid Tumors

United States, Canada, Switzerland
Merck Sharp & Dohme LLC

Recruiting

A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Pulmonary Arterial Hypertension | Hypertension, Pulmonary

United States, Argentina, Australia, Belgium, Canada, Colombia, France, Germany, Israel, Italy, Mexico, New Zealand, Poland, Sweden, Turkey, United Kingdom, Greece, Russian Federation
Merck Sharp & Dohme LLC

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)

Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC

Completed

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)

Hypertension | Isolated Systolic Hypertension
Merck Sharp & Dohme LLC

Completed

A Single Dose Study of MK-8266 (MK-8266-001)

Hypertension
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)

Advanced Cancer
Merck Sharp & Dohme LLC

Withdrawn

A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)

Asthma
Merck Sharp & Dohme LLC

Recruiting

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

HIV | HIV Pre-exposure Prophylaxis

United States, South Africa, Israel
Merck Sharp & Dohme LLC

Completed

A Multiple Dose Study of MK-3614 (MK-3614-002)

Hypertension
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)

Hepatitis C
Merck Sharp & Dohme LLC

Completed

A Study of the Pharmacokinetics of Two Formulations of MK-1006 (MK-1006-010 AM1)(COMPLETED)

Type 2 Diabetes
Merck Sharp & Dohme LLC

Completed

A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)

Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC

Completed

A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)

Hypertension

United States

3

Subscribe